Canadian drug shortage plan fails to tackle problems; analyst
19-Oct-2011 By Nick Taylor
Canadian pharma manufacturers’ plan to stop drug shortages by sharing information fails to tackle underlying concerns, an analyst said.
PPD shares ‘limited’ confidential info with new potential buyer
19-Oct-2011 By Gareth Macdonald
Under offer CRO PPD has signed a confidentiality agreement with another potential buyer according to an SEC filing submitted last week.
CMO Angel & Russian pharma plan drug production JV
18-Oct-2011 By Nick Taylor
Angel Biotechnology is negotiating a joint-venture with a Russian firm that would see it add dedicated production space at a UK site.
Honeywell adds high barrier film for hot & humid climates
18-Oct-2011 By Nick Taylor
Honeywell has introduced a high moisture barrier film to protect sensitive pharmaceuticals in hot and humid climates.
Rusnano and Nearmedic team on nanomedicine manufacturing plant
18-Oct-2011 By Gareth Macdonald
Rusnano and Nearmedic Plus will build a ‘nanomedicine’ production facility in Russia in a collaboration that fits with Government efforts to boost local drug manufacturing.
Patient recruitment hindered by mistrust of clinical trials
18-Oct-2011 By Nick Taylor
Mistrust of clinical trials and poor patient engagement is limiting recruitment into US studies, an IOM forum heard.
Movianto building warehouse as logistics growth continues
17-Oct-2011 By Nick Taylor
Movianto is to open a 13,000 sq m pharmaceutical warehouse in the Netherlands as it continues to expand cold-chain capabilities.
Economic reform drove Indian pharma manufacturing boom
17-Oct-2011 By Nick Taylor
Liberalisation of Indian regulations in the early 90s caused a surge in manufacturing capacity but a dip in efficiency, research claims.
13-Oct-2011 By Nick Taylor
Sproxil and Orange have separately expanded text messaging anti-counterfeiting services in Kenya to tackle fake drugs.
Execs the winners after tax holiday, Senate report says
13-Oct-2011 By Nick Taylor
A Senate report has slammed the ACRO-backed overseas profit tax break for doing more to help execs’ pay packets than US employment.
Competitive concerns limit market access outsourcing
12-Oct-2011 By Nick Taylor
Outsourcing of certain market access tasks is limited by concerns that using vendors will give rivals a competitive advantage, a report found.
Parexel and NUS team on clinical research training academy
11-Oct-2011 By Gareth Macdonald
US CRO Parexel has set out to foster clinical research talent in Singapore through a new training academy
11-Oct-2011 By Gareth Macdonald
The United States Pharmacopeial Convention (USP) has forged closer ties with Russian regulators to help tackle substandard pharmaceuticals and harmonize quality standards.
Drug shortages drive demand surge & expansion at Akorn
10-Oct-2011 By Nick Taylor
Akorn is doubling capacity and hiring “as fast as [it] can” after drug shortages sent demand for its injectables soaring.
Encorium seeks partner or PE buyer after loss of biz
10-Oct-2011 By Nick Taylor
Encorium is seeking a CRO partner or private equity buyer after the strategic outsourcing trend hit its revenues and cash reserves.
ACRO backs proposed tax cuts on earnings generated outside US
update
10-Oct-2011 By Gareth Macdonlad
ACRO has backed plans to reduce the tax rate on foreign earnings sent back to the US, arguing that the move would create jobs in the contract research sector.
Akorn to enter India in five facility takeover deal
06-Oct-2011 By Nick Taylor
Akorn is to expand its CMO business into India and add sterile injectables capabilities by acquiring five manufacturing plants.
Insulin pens & Brazil buy drive Gerresheimer growth
06-Oct-2011 By Nick Taylor
Gerresheimer posted a jump in sales and upgraded guidance on strong demand for insulin pens and the Vedat acquisition.
Avacta allies with Pall to serve SE Asian biopharm
06-Oct-2011 By Nick Taylor
Avacta has allied with Pall to offer biopharm manufacturers in Singapore and South Korea tools to assess formulation viability.
FDA awards $35m to improve US drug production
05-Oct-2011 By Nick Taylor
The FDA has awarded a $35m (€26m) grant to make US drug production less expensive and reverse the offshoring trend.
AmerisourceBergen to buy reimbursement services firm TheraCom for $250m
05-Oct-2011 By Gareth Macdonald
AmerisourceBergen will buy patient access and reimbursement support services firm TheraCom, continuing its recent run of acquisitions.
05-Oct-2011 By Nick Taylor
CROs will expand into Cambodia and Vietnam in response to competition for patients across Asia-Pacific, a Roche manager told PRO 2011.
PPD accepts $3.9bn offer
04-Oct-2011 By Nick Taylor
PPD has agreed to be acquired by two private equity firms for $3.9bn (€3.0bn) in cash.
Aesica plans expansion in US & Asia after investment
03-Oct-2011 By Natalie Morrison
CDMO Aesica is to add manufacturing capacity in Asia and the US following a cash injection from private equity firm Silverfleet Capital.
Investment prompts trial tech expansion at Exco InTouch
03-Oct-2011
Exco InTouch is to accelerate expansion in clinical technology after a venture capital group invested in the company.
Supply chain delays driving up Indian logistics costs
03-Oct-2011 By Nick Taylor
State-border delays, tolls and paperwork are increasing logistics costs in India and making transit less efficient than the EU and China, a report found.
29-Sep-2011 By Nick Taylor
The US FDA has filed a permanent injunction against a US drugmaker and sent a warning letter to a Chinese API producer following cGMP problems.
ProMetic supplying adsorbent to Chinese biosimilar biz
26-Sep-2011 By Nick Taylor
ProMetic Life Sciences is supplying an affinity adsorbent to a Chinese biopharm for use in scale-up of a biosimilar.
Ukraine votes to criminalise drug counterfeiting
26-Sep-2011 By Alexandira Pesic
Ukraine's parliament, the Verkhovna Rada, has voted unanimously in favour of new legislation which will criminalise the production and trafficking of counterfeit drugs.
FDA hits Indian API plant with warning letter & import alert
22-Sep-2011 By Nick Taylor
The FDA has issued a warning letter and import alert to an Indian API manufacturer after finding major cGMP failings.
Lilly boosts minority participation in trial with new systematic approach
22-Sep-2011 By Gareth Macdonald
US pharmaceutical firm Eli Lilly says taking language, cultural diversity and site location into account helped boost ethnic minority participation in a recently completed trial.
Illingworth Research launches contract medical photography service
21-Sep-2011 By Gareth Macdonald
Medical Photography is a potentially valuable yet underused resource in clinical trials according to Illingworth Research, which aims to increase its exposure with a new service.
DHL expands in life sciences with China site & JV takeover
21-Sep-2011 By Nick Taylor
DHL has opened a logistics centre in China and taken full ownership of a cold chain joint venture to expand its life sciences capabilities.
Catalent and Toyobo team up to launch GPEx in Japan
21-Sep-2011 By Natalie Morrison
Catalent has struck up a deal with Toyobo Biologics to launch its cell line engineering technology on the Japanese market.
Rx-360 begins audit sharing to raise ingredient quality
21-Sep-2011 By Nick Taylor
Rx-360 has begun its audit sharing programme to increase knowledge about suppliers and the quality of pharmaceutical raw materials.
Strong R&D spending in China continues despite economic dip
21-Sep-2011 By Nick Taylor
Biopharm is continuing to spend on R&D in China despite the economic dip, and CROs in the region should benefit, an analyst said.
Russian MoH OKs nearly 600 sites for trials
20-Sep-2011 By Gareth Macdonald
The Russian Ministry of Health (MoH) has cleared nearly 600 trial sites for clinical research, easing concerns that the reaccreditation process was taking too long.
CEO hire signals private equity unlikely to buy PPD; analyst
20-Sep-2011 By Nick Taylor
PPD has named a new CEO and is now unlikely to be taken over by private equity because the deal environment has worsened, an equity analyst said.
Frontage and Spaulding team on core lab services and China
20-Sep-2011 By Gareth Macdonald
Frontage Laboratories and Spaulding Clinical Research have teamed up to target China’s rapidly expanding contract research sector.
ShangPharma eyes discovery biology growth with mAb deal
19-Sep-2011 By Nick Taylor
ShangPharma’s emerging discovery biology services unit has inked another antibody development partnership with a Chinese biopharm.
DaVita opens biorepository to support drug discovery
15-Sep-2011 By Nick Taylor
DaVita Clinical Research has opened a biorepository to help drug discovery teams develop personal medicines by understanding patient populations.
Clinpharm Consulting rejigs offering to tackle common PK-PD challenges
15-Sep-2011 By Gareth Macdonald
Drug Developers struggle to find PK-PD providers that are fast and efficient says US CRO ClinPharm Consulting, after launching a new suite of services designed to cut risk and maximize return on R&D investment.
FDA asks for powers to stop another heparin-like crisis
15-Sep-2011 By Nick Taylor
The FDA needs additional powers to update its “antiquated, domestically-focused statute” and end the “competitive advantage of non-compliance”, an agency official said.
vivoPharma opens US preclinical facility
14-Sep-2011 By Gareth Macdonald
Australian preclinical services firm vivoPharma has opened a new vivarium and laboratory facility in the US as part of an effort to expand its global reach.
Biocon building Malaysia plant to serve Pfizer insulin deal
14-Sep-2011 By Nick Taylor
Biocon has begun work on the Malaysian biopharm plant that will serve its deal with Pfizer, and is now providing Lipitor ingredients.
Round up of eClinical news
14-Sep-2011 By Nick Taylor
Outsourcing-Pharma presents a roundup of eClinical news, including developments at BioClinica, OmniComm, ePharmaSolutions and MedNet.
14-Sep-2011 By Gareth Macdonald
Pharma industry sponsors want more effective ways of measuring CRO performance according to the team behind a new project aiming to develop a validated set of analysis tools.
Patheon plans facility exits & capability cuts to improve biz
13-Sep-2011 By Nick Taylor
Patheon is exiting semi-solids, clinical packaging and cutting facilities in response to ‘poor historical performance’.
Big CROs losing out as complex trials favour Phase I specialists
12-Sep-2011 By Nick Taylor
Phase I-focused CROs are winning business from larger rivals as sponsors seek specialists to run more complex studies, market research found.
Aurobindo forms Russian manufacturing JV
08-Sep-2011 By Gareth Macdonald
Contract manufacturing organisation (CMO) Aurobindo Pharma has teamed up with Russian supplement maker OJSC Diod to establish a manufacturing joint-venture.